We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+12.41%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$27.2B
AUM Growth
+$1.69B
Cap. Flow
-$837M
Cap. Flow %
-3.08%
Top 10 Hldgs %
35.28%
Holding
550
New
72
Increased
170
Reduced
177
Closed
71

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$151M
2
JPM icon
JPMorgan Chase
JPM
+$120M
3
QCOM icon
Qualcomm
QCOM
+$115M
4
VRSN icon
VeriSign
VRSN
+$107M
5
FISV
Fiserv Inc
FISV
+$105M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$376M
2
MSFT icon
Microsoft
MSFT
+$285M
3
HD icon
Home Depot
HD
+$167M
4
ABT icon
Abbott
ABT
+$157M
5
SHW icon
Sherwin-Williams
SHW
+$141M

Sector Composition

Rank Sector Weight
1 Technology 32.58%
2 Healthcare 21.35%
3 Consumer Discretionary 13.11%
4 Financials 10.29%
5 Communication Services 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HALO icon
326
Halozyme
HALO
$9.93B
$1.17M ﹤0.01%
66,000
WELL icon
327
Welltower
WELL
$173B
$1.17M ﹤0.01%
14,308
-113,445
-89% -$9.71M
TSN icon
328
Tyson Foods
TSN
$21.9B
$1.15M ﹤0.01%
12,668
-391
-3% -$33.6K
GD icon
329
General Dynamics
GD
$106B
$1.14M ﹤0.01%
6,434
-1,984
-24% -$356K
DCPH
330
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.12M ﹤0.01%
+18,000
New +$855K
CDW icon
331
CDW
CDW
$18.2B
$1.09M ﹤0.01%
7,656
+7,515
+5,330% +$994K
SAGE
332
DELISTED
Sage Therapeutics
SAGE
$1.08M ﹤0.01%
15,000
+7,500
+100% +$923K
CQP icon
333
Cheniere Energy
CQP
$30.6B
$1.08M ﹤0.01%
27,028
RCL icon
334
Royal Caribbean
RCL
$85.7B
$1.06M ﹤0.01%
7,955
COLD icon
335
Americold
COLD
$4.24B
$1.06M ﹤0.01%
30,242
-55,476
-65% -$2.04M
GPRK icon
336
GeoPark
GPRK
$598M
$1.05M ﹤0.01%
47,629
+16,064
+51% +$305K
SPLK
337
DELISTED
Splunk Inc
SPLK
$1.04M ﹤0.01%
+6,937
New +$911K
TPR icon
338
Tapestry
TPR
$30.2B
$1.03M ﹤0.01%
38,311
MKSI icon
339
MKS Inc
MKSI
$19.1B
$1.02M ﹤0.01%
+9,303
New +$975K
KSS icon
340
Kohl's
KSS
$2.18B
$1.02M ﹤0.01%
20,021
ZYME icon
341
Zymeworks
ZYME
$1.66B
$1M ﹤0.01%
+22,000
New +$799K
AFYA icon
342
Afya
AFYA
$1.32B
$997K ﹤0.01%
36,753
+8,000
+28% +$216K
CONE
343
DELISTED
CyrusOne Inc Common Stock
CONE
$988K ﹤0.01%
15,093
-3,710
-20% -$255K
KYNB
344
Kyntra Bio
KYNB
$29M
$986K ﹤0.01%
920
IMMU
345
DELISTED
Immunomedics Inc
IMMU
$973K ﹤0.01%
46,000
+3,000
+7% +$52.9K
GILD icon
346
Gilead Sciences
GILD
$166B
$961K ﹤0.01%
14,783
AUPH icon
347
Aurinia Pharmaceuticals
AUPH
$1.96B
$952K ﹤0.01%
+47,000
New +$433K
FATE icon
348
Fate Therapeutics
FATE
$267M
$939K ﹤0.01%
48,000
+8,000
+20% +$127K
BMRN icon
349
BioMarin Pharmaceuticals
BMRN
$12.1B
$936K ﹤0.01%
11,070
+4,314
+64% +$326K
EQIX icon
350
Equinix
EQIX
$103B
$915K ﹤0.01%
1,567

Similar funds

Fred Alger Management's Q4 2019 Portfolio in Review

As of Q4 2019, Fred Alger Management held 550 positions worth $27.2B, up 6.6% from $25.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Fred Alger Management withdrew a net $837M in Q4 2019, closing 71 positions and reducing 177 holdings. Its most notable exit was iRhythm Holdings, an estimated $39.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Fred Alger Management opened a new position in CrowdStrike worth $41.4M.

  • Fred Alger Management's largest Q4 2019 buy was CrowdStrike: 3,323,112 shares worth $41.4M.
  • Fred Alger Management added most to UnitedHealth in Q4 2019, an estimated $151M increase.
  • Fred Alger Management's biggest Q4 2019 reduction was Amazon, cutting an estimated $376M.
  • Fred Alger Management fully exited iRhythm Holdings in Q4 2019, selling an estimated $39.8M.
  • Fred Alger Management's ten largest holdings make up 35% of its $27.2B portfolio in Q4 2019.
  • Fred Alger Management opened 72 new positions and closed 71 in Q4 2019.
  • Fred Alger Management's portfolio value rose 6.6% quarter-over-quarter to $27.2B.

Based on Fred Alger Management's 13F filing for Q4 2019, filed 14 Feb 2020.